Multicenter Analytical Validation of Aβ40 Immunoassays

BACKGROUND: Before implementation in clinical practice, biomarker assays need to be thoroughly analytically validated. There is currently a strong interest in implementation of the ratio of amyloid-β peptide 1-42 and 1-40 (Aβ42/Aβ40) in clinical routine. Therefore, in this study, we compared the ana...

Descripción completa

Detalles Bibliográficos
Autores principales: van Waalwijk van Doorn, Linda J. C., Kulic, Luka, Koel-Simmelink, Marleen J. A., Kuiperij, H. Bea, Versleijen, Alexandra A. M., Struyfs, Hanne, Twaalfhoven, Harry A. M., Fourier, Anthony, Engelborghs, Sebastiaan, Perret-Liaudet, Armand, Lehmann, Sylvain, Verbeek, Marcel M., Vanmechelen, Eugeen J. M., Teunissen, Charlotte E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497061/
https://www.ncbi.nlm.nih.gov/pubmed/28725210
http://dx.doi.org/10.3389/fneur.2017.00310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497061/
https://www.ncbi.nlm.nih.gov/pubmed/28725210
http://dx.doi.org/10.3389/fneur.2017.00310

Ejemplares similares